Product Images Desvenlafaxine Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Desvenlafaxine Succinate NDC 71335-1331 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - e33fdabd c42d 47bf af0a 1b6d3637f519 01
Image - e33fdabd c42d 47bf af0a 1b6d3637f519 02
Image - e33fdabd c42d 47bf af0a 1b6d3637f519 03
The text describes a figure labeled "Figure 2" which shows the effect of other drugs on the pharmacokinetics of Desvenlafaxine. The figure includes information on the geometric mean ratio with a confidence interval of 90%. The drugs mentioned are CYP3A4 inhibitors such as Ketoconazole. There is also a graph showing changes in AUC. It is unclear what the reference is for this information.*
Image - e33fdabd c42d 47bf af0a 1b6d3637f519 04
The text provides pharmacokinetic data related to the effects of Desvenlafaxine on other drugs. It includes the geometric mean ratio at 90% confidence interval for drugs metabolized by CYP2D6, CYP3A, and CYP2D6&CYP3M substrates. The data is presented in the form of a table with results for Tamoxifen active metabolite Endroxifen and Aripiprazole active metabolite dehydro-aripiprazole.*
Image - e33fdabd c42d 47bf af0a 1b6d3637f519 05
The figure shows the estimated proportion of patients experiencing a relapse over time in Study 5. The horizontal axis represents the number of days since randomization and the vertical axis represents the estimated proportion of relapses, with values ranging from 0% to 50%. The blue line represents the treatment group receiving Desvenlafaxine extended-release tablets 50 mq, while the orange line represents the placebo group. The graph suggests that the Desvenlafaxine group had a lower proportion of relapse cases over time compared to the placebo group.*
Image - e33fdabd c42d 47bf af0a 1b6d3637f519 06
This appears to be a graph depicting the estimated proportion of patients experiencing relapse over time (measured in days) from randomization, with one line representing Desvenlafaxine extended-release tablets and the other representing a placebo. The percentage values for the proportion of patients are not available due to the limitations of .*
Label - lbl713351331
This is a medication package label. It contains information on the medication and dosage instructions. The medication is called Pristig, a 100mg tablet, and is produced by Lupin Limited. The package contains 30 tablets and has an expiry date of MM/YY. The National Drug Code (NDC) is 7133513311. The medication should be stored in a room temperature of 20°-25°C (68°-77°F). The package also includes a warning to keep all drugs out of children's reach. The rest of the text appears to be errors generated by .*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.